Scarica l'app Stockscreener
0.53
6.59%
-0.0374
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché ABVC Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$0.5674
Aprire:
$0.585
Volume 24 ore:
83,475
Relative Volume:
0.61
Capitalizzazione di mercato:
$6.71M
Reddito:
$152.40K
Utile/perdita netta:
$-10.52M
Rapporto P/E:
-0.1366
EPS:
-3.88
Flusso di cassa netto:
$-4.26M
1 W Prestazione:
-3.81%
1M Prestazione:
-1.85%
6M Prestazione:
-50.93%
1 anno Prestazione:
-70.22%
Intervallo 1D:
$0.53
$0.59
Intervallo di 1 settimana:
$0.50
$0.59
Portata 52W:
$0.4053
$2.45
Abvc Biopharma Inc Stock (ABVC) Company Profile
Nome
Abvc Biopharma Inc
Settore
Industria
Telefono
510-668-0881
Indirizzo
44370 OLD WARM SPRINGS BLVD., FREMONT
Confronta ABVC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| ABVC | 0.53 | 6.71M | 152.40K | -10.52M | -4.26M | -3.88 |
| VRTX | 449.66 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 746.01 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 599.51 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 246.36 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 108.11 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Abvc Biopharma Inc Borsa (ABVC) Ultime notizie
ABVC BioPharma Inc. Reports Operational Profit and Income Growth in Q3 2024 - Defense World
ABVC BioPharma Inc. (ABVC) Quarterly 10-Q Report - Quartzy
ABVCABVC BioPharma, Inc. Latest Stock News & Market Updates - StockTitan
ABVC BioPharma Reports First Operational Profit in Q3 2024, Showcasing Significant Financial Improvement - Citybuzz
ABVC BioPharma, Inc. Reports Q3 2024 Financial Results and Operational Milestones - The Manila Times
ABVC BioPharma Reports First-Ever Operational Profit, 2,352% Revenue Surge in Q3 | ABVC Stock News - StockTitan
ABVC BioPharma, Inc. (NASDAQ:ABVC) Sees Large Increase in Short Interest - Defense World
ABVC BioPharma Enters into Agreement to Exercise Warrants at Reduced Price - Defense World
ABVC BioPharma receives $50,000 in incremental licensing fees, shares climb - MSN
ABVC BioPharma secures additional licensing fees - Investing.com
ABVC BioPharma Receives $50,000 in Incremental Licensing Fees, Boosting Total Payments to $346,000 From Its Three Strategic Partners - The Manila Times
ABVC BioPharma secures additional licensing fees By Investing.com - Investing.com UK
ABVC BioPharma switches to new independent accounting firm - Investing.com
ABVC BioPharma switches to new independent accounting firm By Investing.com - Investing.com UK
ABVC BioPharma Inc (ABVC) Stock: The Story of a 52-Week Stock Range - The InvestChronicle
Financial Analysis: Eledon Pharmaceuticals (NASDAQ:ELDN) & ABVC BioPharma (NASDAQ:ABVC) - Defense World
1832 Asset Management L.P. Has $21.08 Million Stock Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Kayne Anderson Rudnick Investment Management LLC Lowers Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Avidity Biosciences initiated with a Buy at Goldman Sachs - TipRanks
ABB unveils number of investors with maximum and minimum stakes in shares - Trend News Agency
ABB (NYSE:ABBNY) Stock Price Passes Above 200 Day Moving Average of $52.74 - MarketBeat
Rhumbline Advisers Sells 495,177 Shares of Ambev S.A. (NYSE:ABEV) - Defense World
Abans Holdings shares: Aditya Birla Money estimates small-cap stock to give multibagger returns. Buy or avoid? | Stock Market News - Mint
ABB (NYSE:ABBNY) Shares Cross Above 200 Day Moving Average of $52.74 - Defense World
Abbott Laboratories (NYSE:ABT) Shares Up 0.3% - MarketBeat
Bank of Montreal Can Trims Stock Holdings in Abbott Laboratories (NYSE:ABT) - Defense World
J. Stern & Co. LLP Has $30.67 Million Position in Abbott Laboratories (NYSE:ABT) - Defense World
Abbott Laboratories (NYSE:ABT) Shares Acquired by Frank Rimerman Advisors LLC - Defense World
ABEV’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle
Xponance Inc. Has $24.89 Million Position in Abbott Laboratories (NYSE:ABT) - Defense World
Abans Holdings Limited gets buy call with target price of Rs 710 | Check details here - India.com
Asset Management Firm Abans Holdings Gets Buy Rating from Aditya Birla MoneyKnow Share Price Target - Times Now
DRW Securities LLC Sells 4,279 Shares of Abbott Laboratories (NYSE:ABT) - Defense World
Profund Advisors LLC Sells 114 Shares of Abbott Laboratories (NYSE:ABT) - Defense World
Anheuser-Busch InBev SA/NV (NYSE:BUD) Shares Sold by Davidson Kempner Capital Management LP - Defense World
It makes sense and dollars to buy ArriVent BioPharma Inc. (AVBP) stock - SETE News
Addus HomeCare price target raised to $145 from $140 at Oppenheimer - TipRanks
American Century Companies Inc. Has $9.70 Million Position in Anheuser-Busch InBev SA/NV (NYSE:BUD) - Defense World
AB Capital breaks out from inverse Head & Shoulder pattern; time to buy? - The Economic Times
ProShare Advisors LLC Acquires 127,133 Shares of Abbott Laboratories (NYSE:ABT) - Defense World
Anheuser-Busch InBev SA/NV (NYSE:BUD) Shares Bought by Heron Bay Capital Management - Defense World
Is AbbVie (NYSE:ABBV) A Risky Investment? - Yahoo Finance
ABIVAX Société Anonyme (NASDAQ:ABVX) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World
Huber Capital Management LLC Has $1.62 Million Stock Holdings in Anheuser-Busch InBev SA/NV (NYSE:BUD) - Defense World
Anheuser-Busch InBev SA/NV (NYSE:BUD) Shares Bought by Callan Capital LLC - Defense World
Abbott Laboratories (NYSE:ABT) Shares Purchased by Ensign Peak Advisors Inc - MarketBeat
Anheuser-Busch InBev SA/NV (NYSE:BUD) Stake Increased by Moors & Cabot Inc. - Defense World
XTX Topco Ltd Invests $2.09 Million in Anheuser-Busch InBev SA/NV (NYSE:BUD) - Defense World
Envestnet Asset Management Inc. Has $35.56 Million Position in Anheuser-Busch InBev SA/NV (NYSE:BUD) - Defense World
Ieq Capital LLC Purchases 2,154 Shares of Abbott Laboratories (NYSE:ABT) - Defense World
AbbVie’s Elahere gets CHMP nod as competition advances - BioCentury
Abvc Biopharma Inc Azioni (ABVC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.80%
0.42%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):